This Stream includes all of our Conference Posters Flipbooks
PBI-4547 Prevents Progression of Prediabetic Condition to Type 1 Diabetes in NOD Mice
PBI-4547 administration in prediabetic type 1 NOD mice significantly prevented the evolution to severe diabetes resulting in increased survival.
PBI-4547 Improves Glucose Metabolism and Insulin Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model of Obesity and Metaboli
Taken together, these results suggest that PBI-4547 offers the potential as a novel therapy for Non-alcoholic fatty liver disease (NAFLD), obesity, type 2 diabetes mellitus, and associated metabolic s
PBI-4050 Improves Metabolic Regulation and Diabetic Nephropathy through Reduction of ER Stress, Pro-Inflammatory/Fibrotic Markers, Galectin-
These results suggest that PBI-4050 is a strong potential candidate for the treatment of metabolic diseases and related diabetic nephropathy.
PBI-4547 Reverses Diabetes and Metabolic Syndrome through Regulation of Lipid/Glucose Metabolism, -Oxidation and Fibrosis in Liver and Whit
PBI-4547 reduces: Blood glucose, cholesterol and triglycerides levels Pro-inflammatory and pro-fibrotic markers in liver Adipocyte size and fibrosis in WAT